Switch to:
Also traded in: Germany, Mexico, Singapore

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 3.16
MR's Cash to Debt is ranked higher than
56% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. MR: 3.16 )
Ranked among companies with meaningful Cash to Debt only.
MR' s Cash to Debt Range Over the Past 10 Years
Min: 0.65  Med: 6.49 Max: No Debt
Current: 3.16
Equity to Asset 0.64
MR's Equity to Asset is ranked higher than
53% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. MR: 0.64 )
Ranked among companies with meaningful Equity to Asset only.
MR' s Equity to Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.72 Max: 0.89
Current: 0.64
0.32
0.89
Interest Coverage 43.61
MR's Interest Coverage is ranked higher than
50% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.88 vs. MR: 43.61 )
Ranked among companies with meaningful Interest Coverage only.
MR' s Interest Coverage Range Over the Past 10 Years
Min: 22.76  Med: 50.20 Max: 6929.25
Current: 43.61
22.76
6929.25
F-Score: 5
Z-Score: 4.05
WACC vs ROIC
9.50%
18.10%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.45
MR's Operating margin (%) is ranked higher than
74% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.54 vs. MR: 14.45 )
Ranked among companies with meaningful Operating margin (%) only.
MR' s Operating margin (%) Range Over the Past 10 Years
Min: 14.55  Med: 20.96 Max: 27.19
Current: 14.45
14.55
27.19
Net-margin (%) 13.19
MR's Net-margin (%) is ranked higher than
81% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. MR: 13.19 )
Ranked among companies with meaningful Net-margin (%) only.
MR' s Net-margin (%) Range Over the Past 10 Years
Min: 14.61  Med: 19.44 Max: 26.52
Current: 13.19
14.61
26.52
ROE (%) 11.12
MR's ROE (%) is ranked higher than
69% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. MR: 11.12 )
Ranked among companies with meaningful ROE (%) only.
MR' s ROE (%) Range Over the Past 10 Years
Min: 12.4  Med: 17.55 Max: 62.71
Current: 11.12
12.4
62.71
ROA (%) 7.18
MR's ROA (%) is ranked higher than
72% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.51 vs. MR: 7.18 )
Ranked among companies with meaningful ROA (%) only.
MR' s ROA (%) Range Over the Past 10 Years
Min: 7.77  Med: 13.95 Max: 31.27
Current: 7.18
7.77
31.27
ROC (Joel Greenblatt) (%) 50.43
MR's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.13 vs. MR: 50.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 57.62  Med: 70.75 Max: 262.34
Current: 50.43
57.62
262.34
Revenue Growth (3Y)(%) 14.50
MR's Revenue Growth (3Y)(%) is ranked higher than
84% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MR: 14.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 14.5  Med: 40.40 Max: 55.3
Current: 14.5
14.5
55.3
EBITDA Growth (3Y)(%) 10.00
MR's EBITDA Growth (3Y)(%) is ranked higher than
58% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. MR: 10.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 23.00 Max: 62.4
Current: 10
0
62.4
EPS Growth (3Y)(%) 5.10
MR's EPS Growth (3Y)(%) is ranked higher than
55% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. MR: 5.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 22.50 Max: 62
Current: 5.1
0
62
» MR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2014

MR Guru Trades in Q4 2014

Caxton Associates 54,200 sh (New)
Jim Simons 927,300 sh (+238.31%)
Frank Sands 634,124 sh (+30.67%)
Frank Sands 634,124 sh (+30.67%)
John Rogers Sold Out
Matthews China Fund 667,668 sh (-29.73%)
» More
Q1 2015

MR Guru Trades in Q1 2015

James Barrow 17,789 sh (New)
Frank Sands 634,224 sh (+0.02%)
Caxton Associates Sold Out
Matthews China Fund 446,868 sh (-33.07%)
Jim Simons 511,800 sh (-44.81%)
» More
Q2 2015

MR Guru Trades in Q2 2015

Jim Simons 541,900 sh (+5.88%)
James Barrow Sold Out
Matthews China Fund Sold Out
Frank Sands 477,384 sh (-24.73%)
» More
Q3 2015

MR Guru Trades in Q3 2015

Jim Simons 741,400 sh (+36.81%)
Frank Sands Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Mindray Medical International Ltd

Matthews China Fund Sells Six Stakes in Second Quarter
The Matthews China Fund (Trades, Portfolio) looks for long-term capital appreciation and invests at least 80 of its assets in Chinese companies. That approach produced returns of 6.84% in 2013 and 11.96% in 2012. In the first half of this year, it returned 18.27%. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 18.22
MR's P/E(ttm) is ranked higher than
78% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.69 vs. MR: 18.22 )
Ranked among companies with meaningful P/E(ttm) only.
MR' s P/E(ttm) Range Over the Past 10 Years
Min: 15.58  Med: 22.56 Max: 95.74
Current: 18.22
15.58
95.74
Forward P/E 14.41
MR's Forward P/E is ranked higher than
83% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.01 vs. MR: 14.41 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 18.22
MR's PE(NRI) is ranked higher than
79% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.80 vs. MR: 18.22 )
Ranked among companies with meaningful PE(NRI) only.
MR' s PE(NRI) Range Over the Past 10 Years
Min: 15.56  Med: 22.58 Max: 96.12
Current: 18.22
15.56
96.12
P/B 2.01
MR's P/B is ranked higher than
61% of the 254 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. MR: 2.01 )
Ranked among companies with meaningful P/B only.
MR' s P/B Range Over the Past 10 Years
Min: 1.74  Med: 3.42 Max: 13.61
Current: 2.01
1.74
13.61
P/S 2.42
MR's P/S is ranked lower than
57% of the 254 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.97 vs. MR: 2.42 )
Ranked among companies with meaningful P/S only.
MR' s P/S Range Over the Past 10 Years
Min: 2.06  Med: 4.30 Max: 25.03
Current: 2.42
2.06
25.03
PFCF 13.38
MR's PFCF is ranked higher than
89% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.61 vs. MR: 13.38 )
Ranked among companies with meaningful PFCF only.
MR' s PFCF Range Over the Past 10 Years
Min: 11.36  Med: 21.74 Max: 145.36
Current: 13.38
11.36
145.36
POCF 9.27
MR's POCF is ranked higher than
85% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.37 vs. MR: 9.27 )
Ranked among companies with meaningful POCF only.
MR' s POCF Range Over the Past 10 Years
Min: 7.88  Med: 16.84 Max: 1294
Current: 9.27
7.88
1294
EV-to-EBIT 11.13
MR's EV-to-EBIT is ranked higher than
80% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.69 vs. MR: 11.13 )
Ranked among companies with meaningful EV-to-EBIT only.
MR' s EV-to-EBIT Range Over the Past 10 Years
Min: 9  Med: 16.80 Max: 90.6
Current: 11.13
9
90.6
EV-to-EBITDA 11.13
MR's EV-to-EBITDA is ranked higher than
71% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.71 vs. MR: 11.13 )
Ranked among companies with meaningful EV-to-EBITDA only.
MR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9  Med: 16.80 Max: 90.6
Current: 11.13
9
90.6
PEG 1.95
MR's PEG is ranked higher than
62% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.99 vs. MR: 1.95 )
Ranked among companies with meaningful PEG only.
MR' s PEG Range Over the Past 10 Years
Min: 0.4  Med: 1.94 Max: 2.54
Current: 1.95
0.4
2.54
Shiller P/E 20.32
MR's Shiller P/E is ranked higher than
84% of the 68 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.62 vs. MR: 20.32 )
Ranked among companies with meaningful Shiller P/E only.
MR' s Shiller P/E Range Over the Past 10 Years
Min: 17.3  Med: 22.72 Max: 33.7
Current: 20.32
17.3
33.7
Current Ratio 2.14
MR's Current Ratio is ranked lower than
61% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. MR: 2.14 )
Ranked among companies with meaningful Current Ratio only.
MR' s Current Ratio Range Over the Past 10 Years
Min: 1.52  Med: 3.29 Max: 6.71
Current: 2.14
1.52
6.71
Quick Ratio 1.89
MR's Quick Ratio is ranked higher than
54% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. MR: 1.89 )
Ranked among companies with meaningful Quick Ratio only.
MR' s Quick Ratio Range Over the Past 10 Years
Min: 1.28  Med: 2.85 Max: 6.24
Current: 1.89
1.28
6.24
Days Inventory 101.58
MR's Days Inventory is ranked higher than
68% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 130.74 vs. MR: 101.58 )
Ranked among companies with meaningful Days Inventory only.
MR' s Days Inventory Range Over the Past 10 Years
Min: 53.51  Med: 80.92 Max: 95.28
Current: 101.58
53.51
95.28
Days Sales Outstanding 48.08
MR's Days Sales Outstanding is ranked higher than
76% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.59 vs. MR: 48.08 )
Ranked among companies with meaningful Days Sales Outstanding only.
MR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.14  Med: 62.67 Max: 83.07
Current: 48.08
24.14
83.07
Days Payable 60.65
MR's Days Payable is ranked higher than
52% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.63 vs. MR: 60.65 )
Ranked among companies with meaningful Days Payable only.
MR' s Days Payable Range Over the Past 10 Years
Min: 42.13  Med: 47.32 Max: 64.83
Current: 60.65
42.13
64.83

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.47
MR's Dividend Yield is ranked higher than
61% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.36 vs. MR: 1.47 )
Ranked among companies with meaningful Dividend Yield only.
MR' s Dividend Yield Range Over the Past 10 Years
Min: 0.34  Med: 1.10 Max: 2.28
Current: 1.47
0.34
2.28
Dividend Payout 0.27
MR's Dividend Payout is ranked higher than
71% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. MR: 0.27 )
Ranked among companies with meaningful Dividend Payout only.
MR' s Dividend Payout Range Over the Past 10 Years
Min: 0.52  Med: 0.96 Max: 1.67
Current: 0.27
0.52
1.67
Dividend Growth (3y) 18.60
MR's Dividend Growth (3y) is ranked higher than
76% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. MR: 18.60 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MR' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 42.2
Current: 18.6
0
42.2
Forward Dividend Yield 1.47
MR's Forward Dividend Yield is ranked higher than
59% of the 150 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. MR: 1.47 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 5.44
MR's Yield on cost (5-Year) is ranked higher than
86% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. MR: 5.44 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MR' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.26  Med: 4.07 Max: 8.43
Current: 5.44
1.26
8.43

Valuation & Return

vs
industry
vs
history
Price/Net Cash 46.15
MR's Price/Net Cash is ranked lower than
52% of the 77 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.17 vs. MR: 46.15 )
Ranked among companies with meaningful Price/Net Cash only.
MR' s Price/Net Cash Range Over the Past 10 Years
Min: 10.34  Med: 15.16 Max: 556.33
Current: 46.15
10.34
556.33
Price/Net Current Asset Value 5.08
MR's Price/Net Current Asset Value is ranked higher than
64% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. MR: 5.08 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4.08  Med: 6.99 Max: 46.21
Current: 5.08
4.08
46.21
Price/Tangible Book 2.89
MR's Price/Tangible Book is ranked higher than
61% of the 230 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.42 vs. MR: 2.89 )
Ranked among companies with meaningful Price/Tangible Book only.
MR' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.32  Med: 4.73 Max: 16.44
Current: 2.89
2.32
16.44
Price/Projected FCF 0.86
MR's Price/Projected FCF is ranked higher than
84% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.64 vs. MR: 0.86 )
Ranked among companies with meaningful Price/Projected FCF only.
MR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.69  Med: 2.67 Max: 12.95
Current: 0.86
0.69
12.95
Price/DCF (Earnings Based) 0.64
MR's Price/DCF (Earnings Based) is ranked higher than
95% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.16 vs. MR: 0.64 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.56
MR's Price/Median PS Value is ranked higher than
88% of the 254 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. MR: 0.56 )
Ranked among companies with meaningful Price/Median PS Value only.
MR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.45  Med: 0.99 Max: 4.2
Current: 0.56
0.45
4.2
Price/Peter Lynch Fair Value 2.44
MR's Price/Peter Lynch Fair Value is ranked lower than
58% of the 71 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.92 vs. MR: 2.44 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MR' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.7  Med: 1.90 Max: 2.43
Current: 2.44
0.7
2.43
Price/Graham Number 1.51
MR's Price/Graham Number is ranked higher than
71% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. MR: 1.51 )
Ranked among companies with meaningful Price/Graham Number only.
MR' s Price/Graham Number Range Over the Past 10 Years
Min: 1.21  Med: 2.17 Max: 6.54
Current: 1.51
1.21
6.54
Earnings Yield (Greenblatt) (%) 8.88
MR's Earnings Yield (Greenblatt) (%) is ranked higher than
88% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MR: 8.88 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.1  Med: 5.90 Max: 11.1
Current: 8.88
1.1
11.1
Forward Rate of Return (Yacktman) (%) 13.41
MR's Forward Rate of Return (Yacktman) (%) is ranked higher than
60% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.04 vs. MR: 13.41 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MR' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 0.7  Med: 13.30 Max: 48
Current: 13.41
0.7
48

More Statistics

Revenue(Mil) $1336
EPS $ 1.49
Beta1.12
Short Percentage of Float1.82%
52-Week Range $21.80 - 33.83
Shares Outstanding(Mil)119.79

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 1,360 1,438
EPS($) 1.63 1.89
EPS without NRI($) 1.63 1.89

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:G2N.Germany, MRN.Mexico, K3QD.Singapore,
Mindray Medical International Ltd was incorporated as an exempted company with limited liability in the Cayman Islands on June 10, 2005 under the Companies Law of the Cayman Islands. The Company is a developer, manufacturer and marketer of medical devices worldwide. The Company operates three primary business segments: patient monitoring and life support products, in-vitro diagnostic products, and medical imaging systems. The Company's patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It currently offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its product line offers customers functionality, such as single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring device. Its multi-parameter monitoring devices can be networked, allowing hospitals to remotely gather patient data from patient rooms and centralize that data in a single location. Its patient monitoring devices also have built-in recorders and have batteries for portability in models, as well as power backup in the event of power failure in mobile models. It also offers a line of veterinary monitoring devices. The Life support products offers anesthesia machines, defibrillators, surgical equipment (including surgical beds and surgical lights ceiling pendants), syringes and infusion pumps, as well as ventilators. The in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. It offers a range of semi-automated and fully-automated in-vitro diagnostic products for laboratories, clinics and hospitals to perform analysis to detect and quantify various substances in the patient samples. Its current product portfolio consists of in-vitro diagnostic products in six product categories: hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products. The hematology analyzers test blood samples to detect abnormalities or foreign substances. The biochemistry analyzers measure the concentration or activity of substances such as enzymes, proteins and substrates. The immunoassay analyzers measure the concentration of protein such as hormone, tumor marker and virus protein. The coagulation analyzers are used to measure activated partial thromboplastin time (APPT), prothrombin time (PT), thrombin time (TT), fibrinogen (FIB), D-Dimer and clotting factor. Urinalysis includes urine sediment and dry chemistry analysis. Urinalysis, together with hematology and biochemistry analysis, are the three common methods used in in
» More Articles for MR

Headlines

Articles On GuruFocus.com
Matthews China Fund Sells Six Stakes in Second Quarter Aug 04 2015 
Matthews China Fund's Top Second Quarter Holdings Jul 31 2014 
Guru Held International Stocks Near 52-Week Lows Jul 31 2014 
Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 16 2014 
The Matthews China Fund's Top Five Fourth Quarter Holdings Feb 04 2014 
12 Healthcare Dividend Stocks With Highest Short Float Ratio Jun 02 2012 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
Notable Dividend Hikes: ALV, PAG, AUY, MR, TCRD May 10 2011 
George Soros’ Sold Out Positions: ANV, DOW, BIDU, CTB, MR, CCC, EDU, SA, FSLR, PWRD, AXL Feb 22 2011 

More From Other Websites
Mindray Announces Extraordinary General Meeting of Shareholders Jan 19 2016
Mindray Announces Extraordinary General Meeting of Shareholders Jan 19 2016
Mindray Announced Shareholder Resolutions Post 2015 Annual General Meeting Dec 29 2015
Mindray Announced Shareholder Resolutions Post 2015 Annual General Meeting Dec 29 2015
MINDRAY MEDICAL INTERNATIONAL LTD Financials Dec 08 2015
Mindray Medical International Ltd. Earnings Q3, 2015 Dec 02 2015
TCF Financial Corporation (TCB): Hedge Funds Are Snapping Up Nov 30 2015
Is Myriad Genetics, Inc. (MYGN) A Good Stock To Buy? Nov 27 2015
Mindray to Hold Annual General Meeting in Hong Kong on December 28, 2015 Nov 25 2015
Mindray Medical and Masimo Agree to Settle All Disputes Nov 24 2015
Mindray Announces Settlement of Previously Described Masimo Related Litigation Nov 20 2015
Mindray Announces Settlement of Previously Described Masimo Related Litigation Nov 20 2015
China Stock Roundup: SINA, ReneSola, JA Solar Beat, JD.com Misses on Earnings Nov 19 2015
Mindray Medical (MR) Q3 Earnings Beat, Revenues Improve Nov 16 2015
Mindray Announces Third Quarter 2015 Financial Results Nov 13 2015
The Zacks Analyst Blog Highlights: Baidu, PetroChina, E-House (China) Holdings, Mindray Medical... Nov 09 2015
China Stock Roundup: Baidu, WuXi PharmaTech Beat, PetroChina Q3 Results Disappoint Nov 06 2015
Mindray Enters into Definitive Merger Agreement for Going Private Transaction Nov 04 2015
Mindray Enters into Definitive Merger Agreement for Going Private Transaction Nov 04 2015
Mindray Medical: Latest Buyout Offer Fails to Cheer Investors Sep 11 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK